MENOPUR Drug Profile
✉ Email this page to a colleague
Summary for Tradename: MENOPUR
Recent Clinical Trials for MENOPUR
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Ferring Pharmaceuticals | Phase 1 |
| Peter Kovacs MD | N/A |
| Laboratoires Genévrier | Phase 3 |
Recent Litigation for MENOPUR
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC | 2018-12-19 |
| Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc. | 2018-05-31 |
| SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP. | 2017-08-08 |
Note on Biologic Patents
Matching patents to biologic drugs is far more complicated than for small-molecule drugs.
DrugPatentWatch employs three methods to identify biologic patents:
- Brand-side disclosures in response to biosimilar applications
- General brand-side disclosures
- Patents from broad patent text search
These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.
These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.
1) High Certainty: US Patents for MENOPUR Derived from Brand-Side Litigation
No patents found based on brand-side litigation
2) High Certainty: US Patents for MENOPUR Derived from Company Disclosures
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2014-04-08 | Company disclosures |
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2016-06-20 | Company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
3) Low Certainty: US Patents for MENOPUR Derived from Patent Text Search
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2033-03-11 | Patent claims search |
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2029-05-13 | Patent claims search |
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2029-01-29 | Patent claims search |
| Ferring Pharmaceuticals Inc. | MENOPUR | menotropins | For Injection | 021663 | See Plans and Pricing | 2035-10-09 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
International Patents for MENOPUR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 4404380 | See Plans and Pricing |
| Portugal | 83278 | See Plans and Pricing |
| Japan | 2000513344 | See Plans and Pricing |
| Japan | S6253999 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for MENOPUR
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| SPC/GB99/045 | United Kingdom | See Plans and Pricing | SPC/GB99/045: 20060829, EXPIRES: 20110828 |
| C990042 | Netherlands | See Plans and Pricing | PRODUCT NAME: INSULIN ASPART; REGISTRATION NO/DATE: EU/1/99/119/001 - EU/1/99/119/005 19990907 |
| 99C0044 | Belgium | See Plans and Pricing | PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615 |
| SZ 50/1999 | Austria | See Plans and Pricing | PRODUCT NAME: INSULIN ASPART |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
